BSE filing, NSE: RALLIS. Summary written from the filing by ALFA Finder's alert engine.
Rallis India Ltd: key numbers
- Share price
- ₹189.90
- Market cap
- ₹3,693 Cr
- Revenue (annual)
- ₹2,897 Cr
- Net profit (annual)
- ₹183.9 Cr
- P/E (TTM)
- 18.8×Sector 34.1×
- Promoter holding
- 55.08%+0.00% QoQ
- FII holding
- 6.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rallis India Ltd
All →Rallis India Earnings Call Transcript: Key Takeaways
Rallis India faced a muted Q2 with flat revenue and declining margins due to erratic rainfall impacting domestic demand and generic pricing pressure in exports.
Rallis India Investor Presentation: Key Takeaways
Rallis India reported flat Q2 revenue and 18% EBITDA decline due to weak monsoons and input cost pressures. Strategy focuses on new product launches and B2B export growth.
Rallis India Q2 FY27 Results: Net Profit ₹85 Cr, Down 16.7% YoY
Rallis India Ltd reported revenue from operations of ₹858 Cr (-0.3% YoY) and net profit of ₹85 Cr (-16.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹85 Cr · -16.7% YoY
Rallis India Other Announcement
The company submitted its quarterly shareholding pattern under SEBI Regulation 31(1)(b) for the quarter ended September 30, 2026.
Rallis India Board Meeting Date
Rallis India Limited will hold a board meeting on October 22, 2026. The meeting will consider and approve unaudited financial results for the second quarter.
Rallis India Credit Rating
CRISIL reaffirmed Rallis India's credit ratings at AA+/Stable (long-term) and A1+ (short-term). The ratings cover ₹440 Crore bank facilities and ₹75 Crore commercial papers.
Other results update announcements
All →Fino Payments Bank Results Update
Fino Payments Bank's press release reports Q2 FY27 revenue of Rs.333.6 Crore and a H1 net loss. Loan referral disbursals surged 286% year-on-year.
Indostar Capital Finance Results Update
IndoStar reported Q2 FY27 standalone results, with disbursements up 51% YoY to ₹1,399 crore. Profit after tax rose to ₹13.1 crore and AUM reached ₹8,459 crore.
Alivus Life Sciences Results Update
Alivus Life Sciences reported Q2FY27 revenue of Rs. 6,820 Mn (up 16.0% YoY) and PAT of Rs. 1,968 Mn in a press release. Investors see record EBITDA margins of 41.8% and capex progress at Solapur and Taloja.
Asset Reconstruction Company (India) Results Update
ARCIL's H1FY27 release shows total income up 48% to Rs.516.4 crore and PAT up 54% to Rs.290.0 crore. Investors should view performance over a longer horizon.
Capital Small Finance Bank Results Update
Capital SFB's Q2 FY27 PAT rose 30.7% year-on-year to ₹45.61 crore, while advances grew 23.4%. Asset quality improved, with GNPA at 2.36% and NNPA at 1.12%.
Strides Pharma Science Results Update
Strides Pharma reported Q2FY27 revenue of ₹14,297m, up 17.1% YoY, and EBITDA of ₹2,509m, up 8.4%, in a press release. Reported PAT rose 2.0% to ₹1,341m.